Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2025)

Maravai Lifesciences Holdings has reported Work In Process over the past 6 years, most recently at $7.3 million for Q4 2025.

  • Quarterly results put Work In Process at $7.3 million for Q4 2025, down 27.18% from a year ago — trailing twelve months through Dec 2025 was $7.3 million (down 27.18% YoY), and the annual figure for FY2025 was $7.3 million, down 27.18%.
  • Work In Process for Q4 2025 was $7.3 million at Maravai Lifesciences Holdings, down from $9.7 million in the prior quarter.
  • Over the last five years, Work In Process for MRVI hit a ceiling of $30.6 million in Q3 2022 and a floor of $7.3 million in Q4 2025.
  • Median Work In Process over the past 5 years was $13.6 million (2023), compared with a mean of $16.8 million.
  • Biggest five-year swings in Work In Process: soared 30.73% in 2022 and later crashed 60.06% in 2023.
  • Maravai Lifesciences Holdings' Work In Process stood at $21.4 million in 2021, then increased by 2.66% to $22.0 million in 2022, then plummeted by 42.23% to $12.7 million in 2023, then dropped by 20.74% to $10.0 million in 2024, then decreased by 27.18% to $7.3 million in 2025.
  • The last three reported values for Work In Process were $7.3 million (Q4 2025), $9.7 million (Q3 2025), and $10.5 million (Q2 2025) per Business Quant data.